A national precision cancer medicine implementation initiative for Norway.

Autor: Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no., Russnes HEG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Aas E; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway., Bjørge L; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Enerly E; Department of Research, Cancer Registry of Norway, Oslo, Norway., Fagereng GL; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Flobak Å; The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Gilje B; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Heix J; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Hovland R; Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway., Lønning PE; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Meza-Zepeda LA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mæhle PM; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Thoresen SØ; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.; Merck AB NUF, Oslo, Norway., Widerberg K; CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway., Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Helland Å; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 885-887.

Implementing cancer patient pathways in Scandinavia how structuring might affect the acceptance of a politically imposed reform.

Autor: Mæhle PM; Department of Health Management an Economy, Faculty of Medicine, University of Oslo and Oslo University Hospital Comprehensive Cancer Centre, Norway. Electronic address: pemm@ous-hf.no., Smeland S; Department of Clinical Medicine, Faculty of Medicine, University of Oslo and Division of Cancer Medicine, Oslo University Hospital Comprehensive Cancer Centre, Norway.

Publikováno v: Health policy (Amsterdam, Netherlands) [Health Policy] 2021 Oct; Vol. 125 (10), pp. 1340-1350. Date of Electronic Publication: 2021 Aug 29.

Practicing Integrated Care Pathways in Norwegian Hospitals: Coordination through Industrialized Standardization, Value Chains, and Quality Management or an Organizational Equivalent to Improvised Jazz Standards.

Autor: Mæhle PM; Institute of Health and Society, Faculty of Medicine, University of Oslo, 0314 Oslo, Norway.; Comprehensive Cancer Centre, Division of Cancer Medicine, Oslo University Hospital, 0450 Oslo, Norway., Small Hanto IK; Comprehensive Cancer Centre, Division of Cancer Medicine, Oslo University Hospital, 0450 Oslo, Norway., Smeland S; Comprehensive Cancer Centre, Division of Cancer Medicine, Oslo University Hospital, 0450 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Dec 09; Vol. 17 (24). Date of Electronic Publication: 2020 Dec 09.